Variant report
Variant | esv3377812 |
---|---|
Chromosome Location | chr2:208910283-208910706 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs564914611 | chr2:208910356-208910357 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs530862495 | chr2:208910358-208910359 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs187166645 | chr2:208910364-208910365 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs370370874 | chr2:208910381-208910382 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs555638126 | chr2:208910384-208910385 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs567421305 | chr2:208910391-208910392 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs13002375 | chr2:208910414-208910415 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs112325947 | chr2:208910415-208910416 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs562692782 | chr2:208910417-208910418 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs560296782 | chr2:208910419-208910420 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs564101135 | chr2:208910422-208910423 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs566200299 | chr2:208910544-208910545 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs538864255 | chr2:208910556-208910557 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs375067896 | chr2:208910586-208910587 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs368385691 | chr2:208910594-208910595 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs377587186 | chr2:208910596-208910597 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs370178284 | chr2:208910599-208910600 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs569332883 | chr2:208910603-208910604 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs374799125 | chr2:208910625-208910626 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs538576704 | chr2:208910644-208910645 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs199993372 | chr2:208910647-208910648 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs200958560 | chr2:208910649-208910650 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs201915954 | chr2:208910650-208910651 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs200192334 | chr2:208910651-208910652 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs182871421 | chr2:208910690-208910691 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ependymoma | 16718352 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Breast cancer | 16272173 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Autism | 16446308 | CNVD |
Autism | 19401682 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Lung cancer | 18438408 | CNVD |
Glioblastoma | 21080181 | CNVD |
Prostate cancer | 18632612 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Papillary thyroid carcinoma | 22161024 | CNVD |
Cervical cancer | 21062161 | CNVD |
Intracranial aneurysm | 16715129 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Prostate cancer | 16573809 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Non-muscle invasive bladder neoplasm | 19445696 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Autism | 20808228 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:208899000-208912000 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
2 | chr2:208905600-208911400 | Weak transcription | Foreskin Keratinocyte Primary Cells skin03 | Skin |
3 | chr2:208907000-208912000 | Weak transcription | Rectal Mucosa Donor 31 | rectum |
4 | chr2:208907000-208913800 | Weak transcription | Fetal Adrenal Gland | Adrenal Gland |
5 | chr2:208908200-208911000 | Weak transcription | H9 Derived Neuron Cultured Cells | ES cell derived |
6 | chr2:208909800-208912000 | Weak transcription | HepG2 | liver |